ACERUS BIOPHARMA INC has a total of 25 patent applications. Its first patent ever was published in 2012. It filed its patents most often in Australia, Republic of Korea and United States. Its main competitors in its focus markets pharmaceuticals and medical technology are TRIMEL BIOPHARMA SRL, EDGE THERAPEUTICS and HALE BIOPHARMA VENTURES LLC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 7 | |
#2 | Republic of Korea | 4 | |
#3 | United States | 4 | |
#4 | EPO (European Patent Office) | 3 | |
#5 | China | 2 | |
#6 | Brazil | 1 | |
#7 | Canada | 1 | |
#8 | Colombia | 1 | |
#9 | Mexico | 1 | |
#10 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Medical technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Syringes |
# | Name | Total Patents |
---|---|---|
#1 | Kreppner Wayne | 14 |
#2 | Oberegger Werner | 14 |
#3 | Maes Paul José Pierre Marie | 9 |
#4 | Fogarty Siobhan | 8 |
#5 | Bryson Nathan | 7 |
#6 | Fogarty Siobban | 6 |
#7 | Maes Paul Jose Pierre Marie | 5 |
#8 | Zwierko Margaux | 5 |
#9 | Westfield Gerwin | 5 |
#10 | Ramasamy Ranjith | 5 |
Publication | Filing date | Title |
---|---|---|
WO2020118437A1 | Active ester derivatives of testosterone, compositions and uses thereof | |
US2021100815A1 | Methods of treating hypogonadism with transnasal testosterone bio-adhesive gel formulations in male with allergic rhinitis, and methods for preventing an allergic rhinitis event | |
US2016175321A1 | Intranasal lower dosage strength testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder | |
CN110613679A | Controlled release nasal testosterone gel, method for nasal administration and prefilled multi-dose applicator system |